| Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer (NCT05364645) | SWOG Cancer Research Network | 2022-07-25 |
| Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease (NCT04836429) | Roswell Park Cancer Institute | 2022-03-10 |
| Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer (NCT05416983) | Mayo Clinic | 2022-02-17 |
| Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study (NCT04987281) | M.D. Anderson Cancer Center | 2022-01-26 |
| A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence (NCT04298606) | Roswell Park Cancer Institute | 2021-11-22 |
| Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer (NCT04989283) | National Cancer Institute (NCI) | 2021-09-09 |
| Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers (NCT04085081) | City of Hope Medical Center | 2021-05-15 |
| Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04625647) | SWOG Cancer Research Network | 2021-04-16 |
| Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer (NCT04705025) | Jonsson Comprehensive Cancer Center | 2021-04-08 |
| Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy (NCT05717998) | Ohio State University Comprehensive Cancer Center | 2021-04-02 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer (NCT03819296) | M.D. Anderson Cancer Center | 2021-02-21 |
| Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study (NCT05022394) | M.D. Anderson Cancer Center | 2021-02-18 |
| Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer (NCT04348292) | Emory University | 2021-01-22 |
| Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer (NCT04913311) | M.D. Anderson Cancer Center | 2021-01-21 |
| Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients (NCT04310020) | National Cancer Institute (NCI) | 2021-01-13 |
| National Cancer Institute "Cancer Moonshot Biobank" (NCT04314401) | National Cancer Institute (NCI) | 2020-11-11 |
| Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use (NCT04694846) | Thomas Jefferson University | 2020-08-19 |
| Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer (NCT04214262) | National Cancer Institute (NCI) | 2020-08-13 |
| Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer (NCT04032418) | Roswell Park Cancer Institute | 2020-08-13 |
| Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer (NCT04946279) | OHSU Knight Cancer Institute | 2020-08-07 |
| Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer (NCT04428905) | City of Hope Medical Center | 2020-07-11 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma (NCT04407247) | M.D. Anderson Cancer Center | 2020-07-09 |
| Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer (NCT05304793) | Ohio State University Comprehensive Cancer Center | 2020-07-01 |
| Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) (NCT04267848) | National Cancer Institute (NCI) | 2020-06-16 |
| Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer (NCT04061590) | University of California, San Francisco | 2020-05-29 |
| Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer (NCT04262869) | Emory University | 2020-03-27 |
| Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer (NCT04073745) | Roswell Park Cancer Institute | 2019-12-04 |
| Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer (NCT04013542) | M.D. Anderson Cancer Center | 2019-09-13 |
| Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study (NCT04430725) | M.D. Anderson Cancer Center | 2019-08-07 |
| CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer (NCT03546361) | Jonsson Comprehensive Cancer Center | 2019-07-08 |
| Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer (NCT03944265) | Thomas Jefferson University | 2019-02-08 |
| Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases (NCT03824327) | Ohio State University Comprehensive Cancer Center | 2019-02-07 |
| Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers (NCT03948100) | M.D. Anderson Cancer Center | 2018-12-20 |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT03707938) | M.D. Anderson Cancer Center | 2018-12-18 |
| Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer (NCT03637816) | M.D. Anderson Cancer Center | 2018-11-27 |
| Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study (NCT03634241) | M.D. Anderson Cancer Center | 2018-11-13 |
| Bronchoscopic Laser Ablation of Peripheral Lung Tumors (NCT03707925) | M.D. Anderson Cancer Center | 2018-09-18 |
| Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer (NCT05106374) | Ohio State University Comprehensive Cancer Center | 2018-09-04 |
| Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study (NCT03410043) | M.D. Anderson Cancer Center | 2018-01-17 |
| Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT03391869) | M.D. Anderson Cancer Center | 2017-12-29 |
| Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer (NCT05740501) | Mayo Clinic | 2017-04-26 |
| CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer (NCT02955290) | Roswell Park Cancer Institute | 2016-12-22 |